Affiliation:
1. Rostov-on-Don Research Anti-Plague Institute
Abstract
A marker of the epidemic significance of Vibrio cholerae is their toxigenicity. Therefore, much attention is currently paid to the creation of diagnostic preparations for the detection of cholera toxin and assessment of the level of its production. The volumetric immunosuspension agglomeration reaction, carried out with the help of latex diagnosticums, is an analogue of the indirect hemagglutination reaction, an affordable and technically simple method, since it does not require special equipment and can be used when conducting research in the field. The aim of the study was to design a polymeric immunoglobulin diagnosticum for determining cholera toxin and the level of its production by vibrio strains. Materials and methods. Cholera toxin was obtained from the producer strain Vibrio cholerae Classical 569 B. Rabbit serum to the toxin was obtained according to the method selected by the authors. A polymeric diagnostic immunoglobulin antitoxic drug was obtained through sensitizing immunoglobulins from cholera antitoxic rabbit serum on the surface of polyacrolein microspheres with a size of (1±0.1) μm. Results and discussion. The analytical sensitivity of the developed diagnostic preparation with control cholera toxin is 100 ng/ml. It detects cholera toxin in toxigenic strains of Vibrio cholerae in a titer of 1:16 – 1:512, gives negative results with non-toxigenic strains of V. cholerae O1, V. Cholerae nonO1/nonO139, with samples of heterologous cultures, LPS preparations, liquid nutrient medium used for the cultivation of V. cholerae. Thus, a polymeric immunoglobulin diagnosticum has been constructed to detect and quantify the production of cholera toxin by vibrio strains, and its analytical sensitivity and specificity have been established.
Publisher
Russian Research Anti-Plague Institute Microbe
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology,Epidemiology
Reference19 articles.
1. WHO – Global Task Force on Cholera Control Target Product Profile (TPP) for the development of improved Cholera rapid diagnostic tests. June 2017. (Cited 20 Mar 2020). [Internet]. Available from: https://www.who.int/cholera/task_force/cholerarapid-diagnostic-test.pdf.
2. WHO. Surveillance standards for vaccine-preventable diseases. Cholera. September 2018. (Cited 20 Mar 2020). [Internet]. Available from: https://www.who.int/docs/default-source/immunization/vpd_surveillance/vpd-surveillance-standards-publication/02-who-surveillancevaccinepreventable-02-cholera-russian-r1.pdf?sfvrsn=a110ae17_10.
3. Sanchez J., Holmgren J. Cholera toxin structure, gene regulation and pathophysiological and immunological aspects. Cell Mol. Life Sci. 2008; 65(9):1347–60. DOI: 10.1007/s00018-008-7496-5.
4. Sanchez J., Holmgren J. Cholera toxin – a foe & a friend. Indian J. Med. Res. 2011; 133(2):153–63.
5. Smirnova N.I., Agafonova N.A., Shchelkanova E.Yu., Rybalchenko D.A., Kritsky A.A., Alkhova Zh.V., Krasnov Ya.M., Agafonova E.Yu., Kutyrev V.V. [Structural and functional changes in the genome of avirulent El Tor biovar Vibrio cholerae ctxA+, tcpA+strains]. Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya [Molecular Genetics, Microbiology and Virology]. 2020; 38(3):108–19. DOI: 10.17116/molgen202038031108.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献